China's pharmaceutical industry has gradually become another gold mine for wealth creation, and a wealthy businessman and his wife have also emerged. "Forbes" newly released the ranking of the world's richest people in 2020. In the health and medical sub-ranking, the top four are all Chinese entrepreneurs. Ranking first and second respectively in the two places are Zhong Huijuan of Hansoh Pharmaceuticals and Sun Piaoyang of Hengrui Pharmaceuticals. The couple's wealth has exceeded 200 billion, and their net worth exceeds that of Wanda and Wang Jianlin, and they have officially become the richest people in Jiangsu.
In China’s medical industry, the names of Mr. and Mrs. Sun Piaoyang may be unfamiliar to outsiders, but most of the drugs that people can come into contact with on a daily basis come from them. company. The personal wealth of Sun Piaoyang and his wife can skyrocket in the short term, mainly because Hansoh Pharmaceutical has entered the financial market. At this stage, the couple respectively controls a listed company, Hengrui Pharmaceutical and Hansoh Pharmaceutical under the two-person group. The market value of the company has exceeded 100 billion yuan, becoming the first husband-and-wife team to have a company with a market value of 100 billion yuan. Behind the wealth legend of Jiangsu's richest couple is a history of reversal for ordinary employees
Sun Piaoyang was born in Jinhu, Huai'an, Jiangsu Province in 1958. In 1982, after graduating from the Huangpu Military Academy of the medical field - China Pharmaceutical University majoring in chemical pharmaceutical technology, he was assigned to Lianyungang Pharmaceutical Company as a technical staff. In the beginning, the plain-looking Sun Piaoyang was not appreciated and was just an ordinary technician in the factory. But Sun Piaoyang's solid technical level eventually made him stand out and was valued by his superiors.
In 1990, the pharmaceutical industry in Lianyungang City was struggling to operate. Sun Piaoyang, then 30 years old, was appointed at the critical moment and took on the heavy responsibility of the director.
Sun Piaoyang, who was born in technology, quickly gave the factory a recipe - to develop and design "new and special" drugs. The next year, he spent huge sums of money to purchase the patent for the new anti-cancer drug ifosfamide, which shocked the factory. Fortunately, this new anti-cancer drug suddenly became a hit in the market for the company after its development. After step by step efforts, Sun Piaoyang successfully led the Lianyungang Pharmaceutical Company to come back to life. In just two years, the pharmaceutical company's revenue increased by RMB 100 million. Sun Piaoyang thus gained a firm foothold in the factory.
Compared with her husband, wife Zhong Huijuan’s way of success is a little different. In 1982, after receiving a bachelor's degree in chemistry from Jiangsu Normal School, Zhong Huijuan worked as a chemistry teacher at Yan'an Middle School in Lianyungang City, and later spent some time at the Lianyungang City Food and Drug Administration. In 1995, her husband Sun Piaoyang cooperated with a Hong Kong CEO to establish a pharmaceutical company. Since Sun Piaoyang could not leave, Zhong Huijuan had no choice but to join Hansoh Pharmaceuticals as the founder, guaranteeing the CEO and CEO along the way. This is a listed company with a total market value of hundreds of billions in the future. The net worth exceeds that of Wanda and Wang Jianlin
In recent years, the net worth of Sun Piaoyang and his wife has changed greatly, and the rate of wealth appreciation can be described as "one change per day."
The Hurun Rich List shows that in 2017, Sun Piaoyang and his wife were worth only 59 billion yuan, ranking 27th in the overall list; in 2018, their worth rose to 82.5 billion yuan, killing Entering the top 20 on the list; by 2019, their ranking has been promoted to 5th, and with a net worth of 175 billion, they have surpassed the "former rich" Wang Jianlin family (with total assets of 120 billion yuan, ranking 9th on the list).
Hengrui Pharmaceuticals, controlled by Sun Piaoyang, is a key enterprise in the production and manufacturing of anti-tumor drugs in China and has the reputation of "Chinese Medicine God" in the medical industry. Some professionals once told the media, "Hengrui Medicine is the leader in China's pharmaceutical industry. Whether it is generic drugs or innovative drugs, its overall level is the strongest."
New closing Data show that Hengrui Medicine's total market value is 368.8 billion yuan, which is 140 billion yuan different from Mindray Medical, which ranks second in A-share market value. Sun Piaoyang owns 21.57% of the shares.
Zhong Huijuan is the head of Hansoh Pharmaceuticals, a company listed on the Hong Kong stock market. The group’s star products are also cancer drugs.
Today, the company's new total market value is HK$14.24 million, once again occupying the top spot among pharmaceutical companies in the Hong Kong stock market. According to the prospectus data, the largest controlling shareholder of Hansen Pharmaceuticals is Stellar Infinity, which holds a position of 75.66, and is jointly owned by Zhong Huijuan, the beneficiary of the family trust Sunrise Trust, and her daughter Sun Yuan.
The financial market never lacks "myths and legends about making wealth"! They have now become the richest couple in Jiangsu Province, and may develop into the richest people in the country in the future. Some experts pointed out that under the influence of today's special period, the development speed of the medical industry may be faster, and the future prospects will be bright, which means that the wealth of the two people will continue to increase. However, compared with the dazzling wealth creation, the higher value of his entrepreneurship lies in saving the world and saving people.